We are live on ! Find out more
NAGE

Niagen Bioscience
NAGE

77 hedge funds and large institutions have $60.5M invested in Niagen Bioscience in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 20 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

220% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 5

20% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 20

17% more funds holding

Funds holding: 66 → 77 (+11)

1.82% more ownership

Funds ownership: 23.01% → 24.83% (+1.8%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

7% less capital invested

Capital invested by funds: $64.9M → $60.5M (-$4.4M)

Holders
77
Holders Change
+11
Holders Change %
+16.67%
% of All Funds
1.55%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
24
Reduced
20
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SA
Sycale Advisors
New York
+$1.02M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$983K
3
TCM
Tieton Capital Management
Washington
+$835K
4
Morgan Stanley
Morgan Stanley
New York
+$829K
5
AQR Capital Management
AQR Capital Management
Connecticut
+$681K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$621K
2
Bessemer Group
Bessemer Group
New Jersey
-$532K
3
MAM
Martingale Asset Management
Massachusetts
-$387K
4
Two Sigma Investments
Two Sigma Investments
New York
-$324K
5
UBS Group
UBS Group
Switzerland
-$247K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$11.2M -$111K -23,044 -0.8%
Vanguard Group
2
Vanguard Group
Pennsylvania
$9.87M +$983K +203,829 +9%
IC
3
Iconiq Capital
California
$6.85M – – –
TCM
4
Tieton Capital Management
Washington
$4.77M +$835K +173,124 +17%
UIC
5
Uniplan Investment Counsel
Wisconsin
$3.62M +$660K +136,757 +18%
State Street
6
State Street
Massachusetts
$2.91M -$26K -5,392 -0.7%
Morgan Stanley
7
Morgan Stanley
New York
$2.56M +$829K +171,900 +37%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$2.52M +$81.3K +16,854 +3%
SA
9
Sycale Advisors
New York
$2.29M +$1.02M +211,958 +59%
Northern Trust
10
Northern Trust
Illinois
$1.95M -$97.9K -20,285 -4%
JMPWA
11
JP Morgan Private Wealth Advisors
California
$1.08M -$48.2K -10,000 -4%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$663K +$165K +34,201 +26%
UBS Group
13
UBS Group
Switzerland
$604K -$247K -51,281 -25%
AQR Capital Management
14
AQR Capital Management
Connecticut
$566K +$681K +141,201 New
N
15
Nuveen
North Carolina
$560K +$3.61K +749 +0.5%
MAM
16
Martingale Asset Management
Massachusetts
$486K -$387K -80,300 -40%
Wells Fargo
17
Wells Fargo
California
$449K +$39.9K +8,269 +8%
Charles Schwab
18
Charles Schwab
California
$386K -$21.4K -4,438 -4%
California Public Employees Retirement System
19
California Public Employees Retirement System
California
$375K +$53.4K +11,065 +13%
RJFSA
20
Raymond James Financial Services Advisors
Florida
$349K +$1.93K +400 +0.5%
Goldman Sachs
21
Goldman Sachs
New York
$345K +$164K +33,908 +65%
ZCM
22
Zebra Capital Management
Connecticut
$332K +$271K +56,083 +210%
Renaissance Technologies
23
Renaissance Technologies
New York
$326K -$621K -128,819 -61%
SO
24
STRS Ohio
Ohio
$315K +$379K +78,600 New
Deutsche Bank
25
Deutsche Bank
Germany
$314K +$95.8K +19,858 +34%
1
2 3 4

NAGE Hedge Fund Activity: Q3 2020 in Review

77 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Niagen Bioscience (NAGE) for Q3 2020, worth a combined $60.5M — down 6.8% from $64.9M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new NAGE positions and 5 closed out — a net gain of 11 holders — while 24 added to existing stakes and 20 trimmed.

The largest buyer was Sycale Advisors, adding an estimated $1.02M. The largest seller was Renaissance Technologies, cutting an estimated $621K.

  • 77 institutional investors held Niagen Bioscience (NAGE) as of Q3 2020, up from 66 in Q2 2020.
  • Funds reported $60.5M of Niagen Bioscience stock for Q3 2020, down 6.8% quarter-over-quarter.
  • 16 funds opened new Niagen Bioscience positions in Q3 2020 and 5 closed out, a net change of +11 holders.
  • The largest Niagen Bioscience buyer in Q3 2020 was Sycale Advisors, an estimated $1.02M added.
  • The largest Niagen Bioscience seller in Q3 2020 was Renaissance Technologies, an estimated $621K sold.

Based on aggregated 13F filings for Q3 2020.